In the wake of safety questions over GlaxoSmithKline's Avandia, FDA is recommending more rigorous testing of diabetes drugs for heart attack and stroke risk. The new recommendations are effective immediately, reports the Wall Street Journal, and they suggest that clinical trials should be redesigned with heart attack and stroke risk assessment in mind, and that any cardiovascular events that occur during the trial should be reviewed by independent, blinded cardiologists.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.